The estimated Net Worth of Robert Coleman is at least $16.2 Milion dollars as of 22 May 2013. Robert Coleman owns over 59,400 units of Masimo Corp stock worth over $14,799,024 and over the last 17 years Robert sold MASI stock worth over $1,447,700.
Robert has made over 2 trades of the Masimo Corp stock since 2012, according to the Form 4 filled with the SEC. Most recently Robert exercised 59,400 units of MASI stock worth $163,350 on 22 May 2013.
The largest trade Robert's ever made was selling 62,000 units of Masimo Corp stock on 30 March 2012 worth over $1,447,700. On average, Robert trades about 8,671 units every 30 days since 2008. As of 22 May 2013 Robert still owns at least 129,600 units of Masimo Corp stock.
You can see the complete history of Robert Coleman stock trades at the bottom of the page.
Robert's mailing address filed with the SEC is C/O MASIMO CORPORATION, 40 PARKER, , IRVINE, CA, 92618.
Over the last 17 years, insiders at Masimo Corp have traded over $198,004,099 worth of Masimo Corp stock and bought 212,683 units worth $10,354,127 . The most active insiders traders include Joe E Kiani, Edward L Cahill a Yongsam Lee. On average, Masimo Corp executives and independent directors trade stock every 14 days with the average trade being worth of $2,669,077. The most recent stock trade was executed by Joe E Kiani on 8 August 2024, trading 231,748 units of MASI stock currently worth $8,769,344.
masimo (nasdaq: masi) is a global medical technology company that develops and manufactures innovative noninvasive patient monitoring technologies, including medical devices and a wide array of sensors. our work is making a measurable difference in the world by saving, extending and improving the lives of people of all ages, in all walks of life for more than 27 years, our innovative medical technologies and noninvasive patient monitoring solutions have been solving ‘unsolvable’ problems. the result is a portfolio of clinically-proven products that lead the way in innovation, performance and patient safety by giving health care providers the information they need to optimize clinical decision-making. masimo is for‘what-ifers’, ‘never-say-never-ers’, and ‘world changers’—people who look beyond what others see. we're looking for people who can, do, and will make a difference. we think you'll like what you see.
Masimo Corp executives and other stock owners filed with the SEC include: